[go: up one dir, main page]

AU4514496A - Novel compounds - Google Patents

Novel compounds

Info

Publication number
AU4514496A
AU4514496A AU45144/96A AU4514496A AU4514496A AU 4514496 A AU4514496 A AU 4514496A AU 45144/96 A AU45144/96 A AU 45144/96A AU 4514496 A AU4514496 A AU 4514496A AU 4514496 A AU4514496 A AU 4514496A
Authority
AU
Australia
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU45144/96A
Inventor
John Duncan Elliott
Stacie Marie Halbert
Jack Dale Leber
Scott Kevin Thompson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/539,451 external-priority patent/US5684032A/en
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU4514496A publication Critical patent/AU4514496A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
AU45144/96A 1994-12-13 1995-12-11 Novel compounds Abandoned AU4514496A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US35535494A 1994-12-13 1994-12-13
US355354 1994-12-13
US08/539,451 US5684032A (en) 1994-12-13 1995-10-05 Compounds
US539451 1995-10-05
PCT/US1995/016084 WO1996018393A1 (en) 1994-12-13 1995-12-11 Novel compounds

Publications (1)

Publication Number Publication Date
AU4514496A true AU4514496A (en) 1996-07-03

Family

ID=26998806

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45144/96A Abandoned AU4514496A (en) 1994-12-13 1995-12-11 Novel compounds

Country Status (4)

Country Link
EP (1) EP0800389A4 (en)
JP (1) JPH10510538A (en)
AU (1) AU4514496A (en)
WO (1) WO1996018393A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000507556A (en) * 1996-03-28 2000-06-20 スミスクライン・ビーチャム・コーポレイション Chemokine carboxylate indole inhibitors
GB9716657D0 (en) * 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
GB9803226D0 (en) 1998-02-17 1998-04-08 Zeneca Ltd Chemical compounds
GB9803228D0 (en) * 1998-02-17 1998-04-08 Zeneca Ltd Chemical compounds
BR9815951A (en) * 1998-07-23 2001-03-06 Smithkline Beecham Corp Il-8 receptor antagonists
GB9902453D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902461D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
AU3634001A (en) * 1999-10-22 2001-05-08 Smithkline Beecham Corporation Indole compounds
FR2801585B1 (en) 1999-11-25 2002-02-15 Fournier Ind & Sante NEW II-8 RECEPTOR ANTAGONISTS
KR20030036917A (en) 2000-10-10 2003-05-09 스미스클라인 비참 코포레이션 SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-γBINDING AGENTS
FR2824826B1 (en) * 2001-05-17 2003-11-07 Fournier Lab Sa NOVEL 5-CYANO-1H-INDOLE DERIVATIVES INTERLEUKIN-8 RECEPTOR ANTAGONISTS
FR2824827B1 (en) * 2001-05-17 2004-02-13 Fournier Lab Sa NOVEL 5-PHENYL-1H-INDOLE ANTAGONIST DERIVATIVES OF INTERLEUKIN-8 RECEPTORS
US7129264B2 (en) * 2003-04-16 2006-10-31 Bristol-Myers Squibb Company Biarylmethyl indolines and indoles as antithromboembolic agents
ATE405549T1 (en) 2004-06-18 2008-09-15 Biolipox Ab INDOLES SUITABLE FOR THE TREATMENT OF INFLAMMATION
DE602005026867D1 (en) 2005-01-19 2011-04-21 Biolipox Ab INFLAMMATORY INDOL DERIVATIVES
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) * 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
UA95788C2 (en) 2005-12-15 2011-09-12 Ф. Хоффманн-Ля Рош Аг Fused pyrrole derivatives
CA2673254C (en) * 2006-12-22 2013-09-10 Schering Corporation 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
US8546431B2 (en) 2008-10-01 2013-10-01 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA939516B (en) * 1992-12-22 1994-06-06 Smithkline Beecham Corp Endothelin receptor antagonists

Also Published As

Publication number Publication date
JPH10510538A (en) 1998-10-13
EP0800389A4 (en) 1998-04-29
WO1996018393A1 (en) 1996-06-20
EP0800389A1 (en) 1997-10-15

Similar Documents

Publication Publication Date Title
AU3382595A (en) Novel compounds
AU5703398A (en) Novel compounds
AU4036895A (en) Substituted 1H-imidazoles
AU3304795A (en) Bisresorcinyltriazines
AU2832295A (en) Cytoanalyzer
AU2837895A (en) Thiazine- or thiazepine-derivatives
AU4514496A (en) Novel compounds
AU2844595A (en) Substituted biphenyloxazolines
AU5423298A (en) Novel compounds
AU2308295A (en) Heterocyclylbenzonitriles
AU1963395A (en) Boom-structure
AU4399396A (en) Compounds
AUPO062696A0 (en) Novel compounds
AU1217797A (en) New compounds
AU3711697A (en) Novel compounds
AU3166195A (en) Acylimidazopyridines
AU3856995A (en) UCF116 Compounds
AU4641497A (en) Novel compounds
AU3166095A (en) Benzylimidazopyridines
AU1603595A (en) Meso-azanoradamantanes
AU2411395A (en) Hydrocopter
AU2301295A (en) Guanidino-substituted compounds
AUPO282996A0 (en) Novel compounds
AUPO282896A0 (en) Novel compounds
AUPO161196A0 (en) Novel compounds